 SEATTLE, May 09, 2022 GLOBE NEWSWIRE -- Impel Pharmaceuticals Inc. NASDAQ: IMPL, a commercial-stage pharmaceutical company developing transformative therapies for people suffering from diseases with high unmet medical needs, with an initial focus on the central nervous system, today announced it will host a live webcast on Monday, May 16, 2022, at 8:30 a.m. ET to report its first quarter 2022 financial results and provide a business update. 